Table 1.
Description of the Intussusception Cases with Brighton Level 1 or 2.
| BL 1 cases N = 151 n (%)a |
All (BL1 & BL2 cases) N = 162 n (%)a |
|
|---|---|---|
|
Age at onset (in days): Mean (SD) Median (IQR) |
227.5 (65.1) 222.0 (178.0–271.0) |
226.3 (64.6) 220.5 (178.0–269.0) |
| Sex: Female | 51 (33.7) | 55 (33.9) |
|
Intestinal location of intussusception Ileocolic Colocolic Ileoileal Othersb Unconfirmed location |
123 (81.5) 4 (2.7) 6 (3.8) 10 (6.6) 8 (5.3) |
127 (78.4) 4 (2.5) 8 (4.9) 11 (6.8) 12 (7.4) |
|
Rotavirus vaccine receivedc Not received ROTAVAC® |
47 (31.1) 104 (68.9) |
49 (30.3) 113 (69.7) |
|
ROTAVAC® vaccination doses Dose 1 Dose 2 Dose 3 |
104 (100.0) 96 (92.3) 92 (88.5) |
113 (100.0) 104 (92.0) 100 (88.5) |
|
Age (in days) at vaccination, Median (IQR) Dose 1 Dose 2 Dose 3 |
50.0 (46.0–57.5) 84.0 (77.0–96.0) 116.0 (110.0–129.0) |
50.0 (46.0–57.0) 83.0 (77.0–96.0) 115.0 (110.0–129.0) |
| Reduction by Surgical methods Surgery with bowel loss or stoma |
61 (40.4) 14 (9.3) |
61 (37.6) 14 (8.6) |
|
Outcome Discharged Death |
150 (99.3) 1 (0.7) |
160 (99.4) 1 (0.6) |
BL1 = Brighton Level 1; BL2 = Brighton Level 2.
a
Unless otherwise specified.
b
Includes - ileo-colocolic, ileo-ileocolic, caecocolic, ileocaecal, ileocaecocolic and jejunduodenal.
c
6/104 received ROTASURE; 8/113 received ROTASURE.